Last reviewed · How we verify

Preventing Recurrent UTI With Vaginal Estrogen (PRUVE)

NCT05551949 PHASE4 COMPLETED Results posted

Among postmenopausal women who suffer from recurrent urinary tract infections (UTI), vaginal estrogen therapy prevents UTI recurrences for 50% of sufferers. This research will investigate why some women benefit but others do not, focusing on (a) the effects of vaginal estrogen therapy on the bacteria that inhabit the vagina and bladder, (b) its influence on immune responses in both compartments, and (c) the extent to which those changes are critical to successful UTI prevention. The findings will be a first step in the development of more effective strategies to prevent UTI, one of the most common and costly benign urologic conditions.

Details

Lead sponsorJohns Hopkins University
PhasePHASE4
StatusCOMPLETED
Enrolment27
Start dateSat Jan 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionSun Aug 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

United States